Lamotrigine vs Tofacitinib
Lamotrigine vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Lamotrigine and Tofacitinib.
Mechanism of Action
Lamotrigine: Sodium channel blocker inhibiting glutamate release.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Lamotrigine β 25 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Lamotrigine β C9H7Cl2N5; Tofacitinib β C16H20N6O.
Molecular Weight: Lamotrigine β 256.0910 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Lamotrigine β Small molecule; Tofacitinib β Small molecule.